UnitedHealth Group Inc., with the ticker symbol UNH, is an American multinational healthcare company that is considered the largest in the world by revenue, topping the Fortune 500 list. Based in Minnetonka, Minnesota, the company offers healthcare products and insurance services to over 130 million individuals worldwide. It was founded in 1977 and has since become an essential part of the US healthcare and wellness industry, employing over 330,000 people and serving millions of clients across the globe.
UnitedHealth Group's operations are divided into two primary business segments: UnitedHealthcare and Optum. UnitedHealthcare offers an expansive spectrum of health benefit programs for individuals, employers, and Medicare and Medicaid beneficiaries, including state programs and the military. UnitedHealthcare is also one of the largest providers of the Medicare Advantage Plan.
Optum, on the other hand, is a health services platform serving the broad health marketplace, including payers, care providers, employers, governments, life sciences companies and consumers. Using advanced data analytics, Optum helps improve overall health system performance and population health management.
Despite being in a highly regulated sector, UnitedHealth Group demonstrates strong financial performance and growth prospects. The company consistently reports solid financial results with high-profit margins and strong cash flows, making it a favored choice among investors seeking steady returns.
UnitedHealth Group retains a leading edge in the industry through a consistent focus on innovation and technology-enabled health services. It continues to invest in new technologies and leverages data analytics to personalize and improve care, enhance the patient experience, and create a more efficient health system.
The company's commitment to health improvement extends to its social responsibility initiatives. UnitedHealth Group has made substantial contributions to public health emergencies and natural disaster relief funds, and continues to invest in social determinants of health to help build healthier, stronger communities.
In summary, UnitedHealth Group Inc. (UNH) is much more than just a leading healthcare company. It is a cornerstone of the American healthcare apparatus, driving innovation, improving healthcare delivery, and working towards the betterment of communities, making it a valuable addition to the U.S healthcare industry and global health ecosystem.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
UnitedHealth (UNH) stock is up 14% in 2026, reaching $376.59 after appointing a new chief administrative officer and elevating its chief commercial officer. The company's Medicaid and Optum Health segments are projected to improve significantly in 2027, with Medicaid margins expected to recover and Optum Health's margins set to expand. Despite potential risks from Medicare Advantage audits and Star ratings, analysts anticipate strong third-quarter adjusted EPS, suggesting that holding or adding to positions before the October 13 earnings report may be favorable.
Humana's stock surged 7% after Barclays upgraded the company to Overweight and raised its price target to $515, extending an already strong year-to-date performance. This rally is company-specific, as other managed care stocks like UnitedHealth saw only modest gains, suggesting the move is driven by analyst sentiment rather than broad sector trends. Investors are now watching for other research firms to follow Barclays' lead, as the sustained gain hinges on wider acceptance of this bullish view before Humana's upcoming quarterly earnings.
Five HCA-affiliated hospitals in Texas have sued Independence Blue Cross, a Philadelphia-based insurer, over $345,000 in allegedly denied or underpaid claims for eight members, including emergency care. The lawsuit claims the insurer violated federal and state law by requiring prior authorization for emergency services and failing to provide specific clinical reasons for denials. This dispute highlights ongoing issues within the BlueCard Program regarding varying authorization rules and medical necessity standards across different Blue Cross Blue Shield plans.